St. Jude Medical, Inc. (NYSE:STJ) today announced it has launched several new cardiac rhythm management devices for the treatment and diagnosis of abnormal heart rhythms.

Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
30
Sep |
St. Jude Medical Announces Australian Launch Of Devices That Diagnose And Treat Abnormal Heart RhythmsCategory: Heart Disease | Leave a Comment |
St. Jude Medical, Inc. (NYSE:STJ) today announced it has launched several new cardiac rhythm management devices for the treatment and diagnosis of abnormal heart rhythms.
|
30
Sep |
Conducting Polymer Nanotubes Take Us A Step Closer To Better Brain ImplantsCategory: Parkinson's Disease | Leave a Comment |
Brain implants that can more clearly record signals from surrounding neurons in rats have been created at the University of Michigan. The findings could eventually lead to more effective treatment of neurological disorders such as Parkinson’s disease and paralysis. Neural electrodes must work for time periods ranging from hours to years. When the electrodes are implanted, the brain first reacts to the acute injury with an inflammatory response.
|
30
Sep |
Highlights Of Medical And Bioscience Research At Frontiers In Optics 2009Category: Medical Devices / Diagnostics | Leave a Comment |
From scopes that help premature babies breathe to techniques for imaging live neurons and beating hearts as they develop, the latest optical and laser technology being deployed in medicine and the biosciences will be on display at the Optical Society’s (OSA) Annual Meeting, Frontiers in Optics (FiO), which takes place Oct. 11-15 at the Fairmont San Jose Hotel and the Sainte Claire Hotel in San Jose, Calif.
|
30
Sep |
Electronic Medical Records Could Help Predict Domestic AbuseCategory: Medical Devices / Diagnostics | Leave a Comment |
Research published on bmj.com today reports that doctors could forecast a patient’s risk of receiving a domestic abuse diagnosis years in advance by using electronic medical records as an early warning system. Dr Ben Reis from the Children’s Hospital Boston Informatics Program and Harvard Medical School is the lead author. Researchers investigated whether the amount of historical electronic data could be used to identify high risk patients.
|
30
Sep |
Improved Robotic Hand Captures Mechanical Engineering Top AwardCategory: IT / Internet / E-mail | Leave a Comment |
The Virginia Tech College of Engineering’s Robotics and Mechanisms Laboratory (RoMeLa) has captured another top award for its updated innovative robotic hand that can automatically change its grasping force using compressed air. A team of five undergraduate students won First Place in the American Society of Mechanical Engineers (ASME) Student Mechanism and Robot Design Competition at the International Design Engineering Technical Conference.
|
30
Sep |
Tool Kit To Help Diagnose Dementia Being Developed By UCF TeamCategory: Alzheimer's / Dementia | Leave a Comment |
With the risk of developing dementia growing at an alarming pace, a University of Central Florida research team is working with the Boston University School of Medicine to develop a miniature diagnostic toolkit in the hopes of stimulating earlier detection and treatment.
|
30
Sep |
Safe, Effective, Minimally Invasive Mitral Valve RepairCategory: Cardiovascular / Cardiology | Leave a Comment |
Surgical treatment for mitral valve disease includes either repairing the patient’s diseased valve or replacing it with a metal, mechanical valve or an animal tissue valve. The majority of those procedures are open-heart operations that require a major incision in the chest.
|
30
Sep |
Excelsior Medical Launches SwabCap To Disinfect Catheter Luer Access ValvesCategory: Medical Devices / Diagnostics | Leave a Comment |
Excelsior Medical, one of the leading manufacturers of pre-filled catheter flush syringes and syringe pump systems, announced that it has launched a major new product: the SwabCap ™ Luer Access Valve Disinfection Cap. SwabCap™ is a simple twist-on device that disinfects swab-able luer access valves prior to catheter line access.
Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for Transcatheter Mitral Valve Implantation (TMVI), announced today that successful results of an acute in vivo study of its TMVI system were disclosed by Dr.
|
29
Sep |
AnnouncementsCategory: Medic | Leave a Comment |